REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,406.00
Bid: 12,404.00
Ask: 12,408.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,406.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

REFILE-US STOCKS-S&P, Nasdaq close at new highs as Wall Street rides bull momentum

Mon, 24th Aug 2020 21:20

(Inserts dropped word in fifth paragraph)

* Apple closes above $500 per share

* Republican National Convention begins

* Energy, financial sectors lead gains

* Indexes up: Dow 1.35%, S&P 1.00%, Nasdaq 0.60%

By Stephen Culp

NEW YORK, Aug 24 (Reuters) - The S&P 500 and the Nasdaq
reached new record closing highs on Monday as optimism over
potential medical advances in the war against the coronavirus
pandemic pushed all three major U.S. stock indexes higher.

The benchmark S&P 500 reclaimed its February closing high
last week, confirming a bull market and the fastest recovery
from a bear market trough on record.

The blue-chip Dow, while leading Monday's gains, remains
nearly 4.2% below its all-time high, and down 0.8% year-to-date.
The Nasdaq and the S&P have gained 26.8% and 6.2%, respectively,
since the final closing bell of 2019.

Of note, the Dow Transports index, often considered a
barometer of U.S. economic health, handily outperformed the
broader market.

"There's been a broadening in this rally and that's what's
reflected in the transports," said Chuck Carlson, chief
executive officer at Horizon Investment Services in Hammond,
Indiana. "(Higher) volume is accompanying this expanding
breadth, and those are all bullish things."

Markets worldwide were given a boost by new developments in
the global race to battle the coronavirus, including an
announcement from the Food and Drug Administration that it had
given emergency authorization for the use of plasma from
recovered patients as a treatment option.

However, the World Health Organization expressed skepticism
about the treatment due to "low quality" data.

The Trump administration is considering fast-tracking an
experimental COVID-19 vaccine being developed by AstraZeneca Plc
and Oxford University in hopes it could be deployed in
the United States before Americans head to the polls in
November.

"There's an element of that news helping the 'reopening
trade,' which is a euphemism of economically sensitive stocks
performing better," Carlson added.

The four-day Republican national convention got under way on
Monday, with the party making the case for Trump's re-election.

On Capitol Hill, Democrats and Republicans remained at
loggerheads over funding levels and unemployment benefits.

Market participants will pay close attention to U.S. Federal
Reserve Chairman Jerome Powell's remarks on monetary policy at
this week's Kansas City Fed Jackson Hole symposium, which is
being held this year in a virtual format.

The Dow Jones Industrial Average rose 378.13 points,
or 1.35%, to 28,308.46, the S&P 500 gained 34.12 points,
or 1.00%, to 3,431.28 and the Nasdaq Composite added
67.92 points, or 0.6%, to 11,379.72.

Of the 11 major sectors in the S&P 500, all but healthcare
ended the session in the black.

Energy and financials enjoyed the largest
percentage gains.

Ahead of its 4-to-1 share split on Friday, Apple Inc
provided the biggest boost to the S&P 500 and the
Nasdaq, its share price closing above $500 days after becoming
the first public U.S. company to top $2 trillion in market
value. The stock gained 1.2%.

Boeing Co gave the Dow its biggest lift, rising 6.4%.

Advancing issues outnumbered declining ones on the NYSE by a
2.52-to-1 ratio; on Nasdaq, a 1.26-to-1 ratio favored advancers.

The S&P 500 posted 45 new 52-week highs and no new lows; the
Nasdaq Composite recorded 84 new highs and 36 new lows.

Volume on U.S. exchanges was 8.94 billion shares, compared
with the 9.53 billion average over the last 20 trading days.
(Reporting by Stephen Culp; Editing by Cynthia Osterman)

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.